Danwei Yu

554 total citations
13 papers, 395 citations indexed

About

Danwei Yu is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Danwei Yu has authored 13 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Virology and 5 papers in Immunology. Recurrent topics in Danwei Yu's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Danwei Yu is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Danwei Yu collaborates with scholars based in China. Danwei Yu's co-authors include Yuanmei Zhu, Yuxian He, Huihui Chong, Hongxia Yan, Lili Ren, Jianwei Wang, Yan Guo, Yusen Zhou, Sheng Cui and Zixuan Liu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Science Advances.

In The Last Decade

Danwei Yu

13 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danwei Yu China 8 323 106 93 80 60 13 395
Zhiwu Sun China 10 222 0.7× 81 0.8× 92 1.0× 61 0.8× 170 2.8× 12 377
Lili Qin China 5 284 0.9× 97 0.9× 21 0.2× 39 0.5× 72 1.2× 7 364
Giulia Piccini Italy 9 359 1.1× 127 1.2× 20 0.2× 62 0.8× 59 1.0× 16 446
Ruthiran Kugathasan United Kingdom 5 447 1.4× 137 1.3× 32 0.3× 59 0.7× 53 0.9× 7 532
Haiying Wang China 12 197 0.6× 101 1.0× 94 1.0× 54 0.7× 100 1.7× 34 381
Toong Seng Tan Japan 8 331 1.0× 150 1.4× 50 0.5× 45 0.6× 35 0.6× 16 412
Mujahed I. Mustafa Sudan 8 161 0.5× 212 2.0× 35 0.4× 85 1.1× 42 0.7× 20 334
Aurelio Bonavia United States 8 421 1.3× 124 1.2× 33 0.4× 121 1.5× 189 3.1× 14 625
Saathvik R. Kannan United States 5 310 1.0× 136 1.3× 34 0.4× 27 0.3× 36 0.6× 7 400

Countries citing papers authored by Danwei Yu

Since Specialization
Citations

This map shows the geographic impact of Danwei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danwei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danwei Yu more than expected).

Fields of papers citing papers by Danwei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danwei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danwei Yu. The network helps show where Danwei Yu may publish in the future.

Co-authorship network of co-authors of Danwei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Danwei Yu. A scholar is included among the top collaborators of Danwei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danwei Yu. Danwei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yu, Danwei, Yuanmei Zhu, Tao Jiao, et al.. (2021). Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants. Emerging Microbes & Infections. 10(1). 1227–1240. 25 indexed citations
2.
Yu, Danwei, et al.. (2021). Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus. Emerging Microbes & Infections. 10(1). 810–821. 17 indexed citations
3.
Wei, Huamian, et al.. (2020). Defective HIV-1 envelope gene promotes the evolution of the infectious strain through recombination in vitro. BMC Infectious Diseases. 20(1). 569–569. 1 indexed citations
4.
Zhu, Yuanmei, Danwei Yu, Hongxia Yan, Huihui Chong, & Yuxian He. (2020). Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity. Journal of Virology. 94(14). 172 indexed citations
5.
Zhu, Yuanmei, Danwei Yu, Yang Han, et al.. (2020). Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals. Science Advances. 6(45). 49 indexed citations
6.
Yu, Danwei, Xiaohui Ding, Yuanmei Zhu, et al.. (2020). Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors. Viruses. 12(3). 326–326. 2 indexed citations
7.
Yu, Danwei, Jing Xue, Huamian Wei, et al.. (2020). Therapeutic Efficacy and Resistance Selection of a Lipopeptide Fusion Inhibitor in Simian Immunodeficiency Virus-Infected Rhesus Macaques. Journal of Virology. 94(15). 4 indexed citations
8.
Zhu, Yuanmei, Huihui Chong, Danwei Yu, et al.. (2019). Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity. Journal of Virology. 93(11). 39 indexed citations
9.
Zhu, Yuanmei, Xiaohui Ding, Danwei Yu, Huihui Chong, & Yuxian He. (2019). The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors. Journal of Virology. 94(1). 6 indexed citations
10.
11.
Yu, Danwei, Xiaohui Ding, Zixuan Liu, et al.. (2018). Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial–approved membrane fusion inhibitor. Journal of Biological Chemistry. 293(33). 12703–12718. 23 indexed citations
12.
13.
Liu, Zixuan, Xiaohui Ding, Danwei Yu, et al.. (2018). Mechanism of HIV-1 Resistance to an Electronically Constrained α-Helical Peptide Membrane Fusion Inhibitor. Journal of Virology. 92(7). 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiwu Sun Breakdown of academic impact, for papers by Lili Qin Breakdown of academic impact, for papers by Giulia Piccini Breakdown of academic impact, for papers by Ruthiran Kugathasan Breakdown of academic impact, for papers by Haiying Wang Breakdown of academic impact, for papers by Toong Seng Tan Breakdown of academic impact, for papers by Mujahed I. Mustafa Breakdown of academic impact, for papers by Aurelio Bonavia Breakdown of academic impact, for papers by Saathvik R. Kannan
Rankless by CCL
2026